Masa Life Science Fund
4
10M
3
0.25
1
- Stages of investment
- Areas of investment
Summary
The venture was found in North America in United States. The main office of represented VC is situated in the Washington.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Cytox, MediQuest Therapeutics. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Masa Life Science Fund, startups are often financed by Novo Holdings, National Institutes of Health, Kentucky Science and Technology Corporation (KSTC). The meaningful sponsors for the fund in investment in the same round are Integra Ventures, Qi3 Ventures, Pegasus Capital. In the next rounds fund is usually obtained by Wren Capital, Kentucky Science and Technology Corporation (KSTC), Walking Ventures.
Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this Masa Life Science Fund performs on 4 percentage points less the average number of lead investments. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2009.
The current fund was established by Sinclair Dunlop. Besides them, we counted 2 critical employees of this fund in our database.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.25
- Investments by industry
- Biotechnology (4)
- Therapeutics (3)
- Health Care (3)
- Drug Discovery (2)
- Therapeutic Devices (2) Show 3 more
- Investments by region
-
- United States (3)
- United Kingdom (1)
- Peak activity year
- 2009
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cytox | 24 Jun 2009 | Biotechnology, Genetics | Seed | 822K | United Kingdom, England, Manchester |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.